Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07458659 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07458659
- Sponsor
- Chulalongkorn University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.